Product Images Rizatriptan Benzoate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Rizatriptan Benzoate NDC 0378-1403 by Mylan Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Rizatriptan Benzoate Tablets 5 mg Bottle Label - image 01
This text appears to be a medication label. It provides instructions for a specific medication called "St of et benzoat, usp" which is equivalent to 5 mg of Rizatriptan. It indicates the usual dosage and cautions the reader to keep the medication away from children. The label also provides information about the manufacturer and a unique code to track the medication. The medication should be kept in a tightly closed, light-resistant container as defined by USP. Additionally, the label includes information about lot number, expiration date, and variable data online coding.*
Rizatriptan Benzoate Tablets 10 mg Bottle Label - image 02
This is a medication information sheet for Rizatriptan tablets. Each tablet contains 10 mg of Rizatriptan, which is a medication used to treat migraines. The details of dosage and precautions are available in the accompanying prescribing information. The medication should be kept out of reach of children and dispensed in a tightly closed container. The code number of the medication is MH/DRUGS/25/NKD/89, and it is manufactured by Mylan Pharmaceuticals Inc. in India. The sheet also contains information on variable data coding and prompt "LOT" and "EXP" for printing.*
Rizatriptan Benzoate Structural Formula - image 03
Figure 1: Estimated Probability of Achieving an Initial Headache Response by 2 Hours in Pooled Studies 1, 2, 3, and 4* - image 04
The text provided is not readable.*
Figure 2: Estimated Probability of Patients Taking a Second Dose of Rizatriptan Benzoate Tablets or Other Medication for Migraines Over the 24 Hours Following the Initial Dose of Study Treatment in Pooled Studies 1, 2, 3, and 4* - image 05
This appears to be a table or graph showing the percentage of a certain substance or drug (Rizatriptan Benzoate Tablets) at different times after it has been taken. There is no further useful information available.*
Figure 5: Observed Percentage of Patients Reporting No Headache Pain by 2 Hours Post-Dose in Study 7 - image 06
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.